Yazar "Kurtuncu M." için listeleme
-
CXCL13 Levels Indicate Treatment Responsiveness to Fingolimod in MS Patients
Karaaslan Z.; Kurtuncu M.; Akcay H.I.; Gunduz T.; Altunrende B.; Turkoglu R.; Eraksoy M. (S. Karger AG, 2022)[No abstract available] -
Mycophenolate mofetil as a novel immunosuppressant in the treatment of neuro-Behçet's disease with parenchymal involvement: Presentation of four cases
Shugaiv E.; Tüzün E.; Mutlu M.; Kiyat-Atamer A.; Kurtuncu M.; Akman-Demir G. (2011)Background. Behçet's disease is a multisystemic, relapsing, inflammatory disorder of unknown origin. Among Turkish cohorts, 5-15% of patients show involvement of the central nervous system (CNS) at some time during their ...